In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae

Medical Mycology

Volumn 36, Issue 6, 1998, Pages 437-440

  Barchiesi, Francesco ^a   Arzeni, Daniela ^a   Compagnucci, Patrizia ^a   Di Francesco, Luigi Falconi ^a   Giacometti, Andrea ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

In vitro susceptibility testing; Saccharomyces cerevisiae

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; NITROGEN; PYRROLE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; ELECTROPHORESIS; FECES CULTURE; HUMAN; KARYOTYPING; NONHUMAN; SACCHAROMYCES CEREVISIAE; SPECTROPHOTOMETRY;

SACCHAROMYCES CEREVISIAE;

EID: 33746395946     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219880000701     Document Type: Article

References (12)

1. Anaisse E, Bodey GP, Kantarjan H, et al. New spectrum of antifungal infections in patients with cancer. Rev Infect Dis 1989; 11: 369-78.
2. Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive infection with S. cerevisiae: report of three cases and review. Rev Infect Dis 1990; 12: 406-11.
3. Cimolai N, Gill MJ, Church D. S. cerevisiae fungemia: case report and review of the literature. Diagn Microbiol Infect Dis 1987; 8: 113-7.
4. Arzeni D, Del Poeta M, Simonetti O, et al. Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy. Eur J Epidemiol 1997; 13: 447-50.
5. Clemmons KV, McCusker H, Davis RW, Stevens DA. Comparative pathogenesis of clinical and nonclinical isolates of S. cerevisiae. J Infect Dis 1994; 169: 859-67.
6. Clemmons KV, Hanson D, Stevens DA. Colony phenotype switching in clinical and non-clinical isolates of Saccharomyces cerevisiae. J Med Vet Mycol 1996; 34: 259-64.
7. McCusker JH, Clemmons KV, Stevens DA, Davis RW. Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42°C and form pseudohyphae. Infect Immun 1994; 63: 478-85.
8. Sobel JD, Vasquez J, Lynch M, Meriwether C, Zerbos MJ. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspect and theraphy. Clin Infect Dis 1993; 16: 93-9.
9. Tiballi RN, Spiegel JE, Zarins LT, Kauffman CA. Saccharomyces cerevisiae infections and antifungal susceptibility study by colorimetric and broth macrodilution method. Diagn Microbiol Infect Dis 1995; 23: 135-40.
10. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibilty testing for yeasts. Tentative standard M27-T. Wayne, PA: NCCLS, 1995.
11. Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994; 97: 339-46.
12. Zerva L, Hollis RJ, Pfaller MA. In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates. J Clin Microbiol 1996; 34: 3031-4.